Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma

Background: Multiple myeloma is a disease of the elderly. However, 40% of patients are diagnosed before 65 years old. Outcomes regarding age as a prognostic factor in MM are heterogeneous. Method: We retrospectively analyzed clinical characteristics, response to treatment and survival of 282 patient...

Full description

Bibliographic Details
Main Authors: Virginia Bove, David Garrido, Eloisa Riva
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Age
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920301139